home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
TIME: Almanac 1995
/
TIME Almanac 1995.iso
/
time
/
080690
/
0806350.000
< prev
next >
Wrap
Text File
|
1994-03-25
|
3KB
|
79 lines
<text id=90TT2078>
<title>
Aug. 06, 1990: Battle Over The Abortion Pill
</title>
<history>
TIME--The Weekly Newsmagazine--1990
Aug. 06, 1990 Just Who Is David Souter?
</history>
<article>
<source>Time Magazine</source>
<hdr>
MEDICINE, Page 79
Battle over the Abortion Pill
</hdr>
<body>
<p>Pressure is mounting to introduce the drug RU 486 in the U.S.
</p>
<p> If maintaining a woman's right to have an abortion tops the
agenda of pro-choice forces, then introducing RU 486, the
so-called abortion pill, into the U.S. ranks second. So far the
foes of abortion have managed to keep the French-made drug out
of the country. But last week a delegation of American
feminists and scientists met in Paris with executives of
Roussel Uclaf, the French company that manufactures the drug,
and in Frankfurt with officials from Hoechst AG, Roussel's
parent company. The Americans presented a petition signed by
115,000 people urging the distribution of RU 486 in the U.S.
American support for the drug has also been growing rapidly
among physicians. In June the American Medical Association
passed a resolution supporting the "legal availability of RU
486 for appropriate research and, if indicated, clinical
practice."
</p>
<p> Judged simply on efficacy and safety, RU 486 marks a major
advancement over other pregnancy-ending techniques. The drug,
which is most effective if used within seven weeks of
conception, prevents the hormone progesterone from being
absorbed by the lining of the uterus. Without that nourishment
the uterus cannot support the growth of the embedded
fertilized egg, and the woman miscarries. Taken with
prostaglandin, a naturally occurring substance that causes mild
uterine contractions, the drug is 95% effective. Developed in
1982 by Dr. Etienne-Emile Baulieu, RU 486 has so far been used
by an estimated 55,000 women in 15 countries.
</p>
<p> France and China in 1988 formally approved use of the drug,
and Roussel will shortly apply to market it in Britain. The
company has refused to export it to any country unless several
conditions are met, including the legality of abortion and its
acceptance by public, political and medical opinion. According
to Ariel Mouttet, head of international marketing for RU 486
at Roussel, the sticking point in the U.S. is the political
climate. Says she: "We don't want to enter into a social debate
in the U.S."
</p>
<p> American advocates of RU 486 contend that the company is
overestimating the opposition. A Louis Harris survey released
last week found that 73% of American adults support abortion
rights. Supporters believe that acceptance of RU 486 in other
countries will lead women to push harder to bring it to the
U.S. Doctors also warn that if the drug is not made officially
available in the U.S., a black market for it will develop.
</p>
<p> Determined pro-choicers say RU 486 could enter the U.S.
through the back door. The drug has potential as a therapy for
endometriosis and breast cancer. If RU 486 were approved to
treat these conditions, doctors could also prescribe it for
abortions. Roussel opposes any deception. Says Dr. Baulieu: "RU
486 has to be sold as the abortion pill that it is."
</p>
<p>By Anastasia Toufexis. Reported by Andrew Purvis/ New York and
Alexandra Tuttle/Paris.
</p>
</body>
</article>
</text>